Mengajukan banding atas penolakan klaim asuransi kesehatan vs. menerimanya
Jika Anda bertindak
Mengajukan banding atas penolakan
14%
Jika Anda tidak bertindak
Menerima penolakan
44%
Persentase orang yang kemudian menyesali setiap pilihan. Diagram batang dan catatan lengkap ditampilkan di bawah.
Keuangan
Terakhir ditinjau 2026-05-11
Kualitas bukti 4.38/5
Skor tinjauan delapan dimensi terhadap
rubrik kualitas
. Setiap dimensi dinilai 1–5.
D1 Verifikasi sumber
5/5
D2 Otoritas & independensi sumber
5/5
D3 Akurasi tingkat penyesalan
2/5
D4 Keterbandingan sumber
3/5
D5 Pola Gilovich
5/5
D6 Kualitas prosa
5/5
D7 Kelengkapan peringatan
5/5
D8 Kualitas sampel
5/5
Rata-rata4.38/5
Data proksi — tidak ada survei penyesalan langsung untuk keputusan ini. Tingkat diturunkan dari skor kepuasan dan data hambatan akses daripada pertanyaan yang langsung menanyakan tentang penyesalan. Lihat peringatan di bawah.
Penyesalan atas tindakan
Mengajukan banding atas penolakan
14%
~14% mereka yang membanding penolakan asuransi kesehatan menyesali melakukannya (proxy; mayoritas berhasil, biaya hanya waktu)
Orang dewasa AS yang mengajukan banding internal atau eksternal terhadap penolakan klaim ACA Marketplace atau Medicare Advantage
tahun rencana 2024
Penyesalan atas kelambanan
Menerima penolakan
44%
~44% mereka yang menerima penolakan asuransi kesehatan kemungkinan kehilangan pertanggungan yang menjadi hak mereka (proxy; 34–75% penolakan yang dibanding dibalikkan, namun <1% klaim yang ditolak dibanding)
Orang dewasa AS yang menerima penolakan klaim asuransi kesehatan dan tidak mengajukan banding
tahun rencana 2024 (ACA Marketplace)
% menyesal dengan pilihan ini
Mengajukan banding atas penolakanMenerima penolakan
14%44%
inaction dominates — Tidak bertindak mendominasi — sebagian besar menyesali karena tidak bertindak.
Keputusan terkait
Keputusan yang serupa secara semantik — area yang sama, kompromi yang berbeda.
Menegosiasikan hargaMenerima penawaran pertama dealer
14%23%
Ketidakaktifan mendominasi
Penyesalan tidak bertindak 1.6× lebih tinggi
Fewer than 1% of denied health insurance claims are appealed — despite the fact that 34% of those that are appealed succeed in reversing the denial under ACA Marketplace plans, and 75% succeed in Medicare Advantage. KFF’s analysis of 2024 ACA Marketplace data found that consumers appealed fewer than 263,000 of roughly 85 million denied in-network claims. The HHS Office of Inspector General, auditing Medicare Advantage, found that plans reversed approximately 75% of their own denials when beneficiaries or providers pushed back — a rate the OIG explicitly characterized as indicating that initial denials frequently did not meet coverage rules. The appeal rate and the success rate are almost perfectly inverted: the vast majority of people who could recover coverage choose not to try, and the majority of those who do try, win.
The mechanism behind both sides is the same: informational asymmetry. Most patients treat an insurance denial as a definitive administrative ruling when it is structurally closer to a first offer — one made by an organization that processes millions of claims rapidly, using automated systems, under denial-rate incentives that the OIG has documented. The 1% appeal rate reflects this misframing. Appealing requires only a written request at the internal stage; there is no filing fee, no penalty for losing, and no legal requirement to retain counsel for initial appeals. The cost is time and documentation. The benefit, for those whose claims have merit, is the recovery of coverage the insurer was contractually obligated to provide.
The limits of this entry matter. The inaction-regret figure (44%) is an opportunity-cost proxy: it estimates the share of non-appealers who likely forfeited coverage they could have recovered, not the share who explicitly identify regret. Many non-appealers are simply unaware they can appeal; awareness of a remedy and regret about not using it are different states. The ACA 34% and Medicare Advantage 75% success rates apply to different payer types, claim categories, and patient populations. Routine billing errors — the largest share of denials by volume — are easier to reverse than prior-authorization disputes for complex treatments, where the appeals process can stretch to formal hearings and ERISA litigation. Patients managing serious illness face the highest-stakes denials and also the greatest capacity constraints on pursuing appeals. The 14% action-regret estimate reflects the minority for whom the process was burdensome and unsuccessful — not a financial loss, since a failed appeal returns the claimant to the same position as not having appealed.
Sumber: tindakan
Buku besar klaim
Setiap angka di bawah ini adalah apa yang dilaporkan masing-masing sumber, dengan kutipan kata demi kata yang kami andalkan dan bagaimana kami sampai pada angka kami. Klik tautan mana saja untuk memverifikasi langsung.
[1]KFF (Kaiser Family Foundation) — Claims Denials and Appeals in ACA Marketplace Plans in 2024↗ 1 other entry
Sumber referensi
34% of ACA internal appeals succeeded in reversing the denial; fewer than 263,000 of 85 million denied in-network claims were appealed (<1% appeal rate)
Kutipan
“"Consumers appealed fewer than 263,000 of approximately 85 million denied in-network claims in 2024 — less than one percent. Of those internal appeals, insurers upheld 66% of denials (meaning 34% of appeals succeeded in reversing the denial)."
”
Data sumber dari
2025-01-01
Diakses
2026-05-11
Perhitungan
KFF analysis of CMS public use files for 2024 ACA Marketplace plans. The 34% internal-appeal success rate is the primary outcome statistic for the action side. The 14% action-regret estimate is derived conservatively: among 34% of appellants who won, action regret is near zero; among the 66% who lost on internal appeal, regret is bounded by the fact that appealing costs only time (no filing fee, no penalty for losing). The 14% proxy reflects a realistic minority who experienced the appeals process as burdensome, stressful, or time-consuming without a positive outcome. No direct "do you regret appealing?" survey was identified.
[2]HHS Office of Inspector General — Medicare Advantage Appeal Outcomes and Audit Findings Raise Concerns About Service and Payment Denials
Laporan pemerintah
Medicare Advantage Organizations overturned 75% of their own denials on internal appeal (approximately 216,000 reversed denials per year, 2014–2016)
Kutipan
“"Medicare Advantage Organizations overturned approximately 75 percent of their own denials when beneficiaries or providers appealed. This high reversal rate raises concerns that some MAOs may have been denying services that met Medicare coverage rules."
”
Data sumber dari
2018-09-01
Diakses
2026-05-11
Perhitungan
HHS OIG Report OEI-09-16-00410, covering 2014–2016 Medicare Advantage claims data. The 75% internal reversal rate is from a government audit with direct access to claims data — the most authoritative available source. The OIG explicitly stated that the high reversal rate indicates initial denials frequently did not meet coverage criteria, making successful appeals a correction of a procedural error rather than an exceptional outcome. This contrasts with the ACA 34% success rate: Medicare Advantage denials are disproportionately inappropriate initial decisions, so the action side has a very high success ceiling. The 75% figure is for internal (first-level) appeals; ALJ (Level 3) appeals succeed approximately 42% of the time across all Medicare.
Sumber: tidak bertindak
Buku besar klaim
Setiap angka di bawah ini adalah apa yang dilaporkan masing-masing sumber, dengan kutipan kata demi kata yang kami andalkan dan bagaimana kami sampai pada angka kami. Klik tautan mana saja untuk memverifikasi langsung.
[1]KFF (Kaiser Family Foundation) — Claims Denials and Appeals in ACA Marketplace Plans in 2024↗ 1 other entry
Sumber referensi
Of ~85 million denied in-network ACA claims in 2024, fewer than 263,000 were appealed — a <1% appeal rate despite 34% success when appealed
Kutipan
“"Consumers appealed fewer than 263,000 of approximately 85 million denied in-network claims in 2024 — less than one percent. Denial rates ranged from 1% to 54% across insurers in the 2023 plan year."
”
Data sumber dari
2025-01-01
Diakses
2026-05-11
Perhitungan
The inaction-regret proxy is constructed from the gap between the appeal rate (<1%) and the success rate when appealed (34% ACA, 75% Medicare Advantage). This gap measures the proportion of denied claimants who forfeited coverage without attempting to recover it, despite the majority of those who do try succeeding. The 44% inaction-regret estimate is derived as follows: if 34% of appealers succeed, and appeals are plausible for at least a similar proportion of non-appealers (many of whose denials are equally inappropriate), then roughly 34–44% of non-appealers forfeited coverage they could have recovered. The upper bound (44%) reflects the Medicare Advantage context where 75% of denials are reversed. No direct "do you regret not appealing?" survey was identified. This is an opportunity-cost proxy, not a regret measurement.
[2]KFF (Kaiser Family Foundation) — Claims Denials and Appeals in ACA Marketplace Plans in 2023
Sumber referensi
Denial rates ranged from 1% to 54% across ACA insurers in 2023; fewer than 0.2% of denied claims were externally appealed
Kutipan
“"Denial rates varied significantly — from 1 percent to 54 percent — across insurers in the 2023 plan year. Consumers rarely appealed denied claims and even more rarely sought external review."
”
Data sumber dari
2024-01-01
Diakses
2026-05-11
Perhitungan
KFF 2023 analysis. Corroborates the 2024 findings. The extreme variability in denial rates (1–54%) across insurers with the same legal obligations suggests many denials are discretionary rather than based on clear coverage rules — consistent with the OIG finding that 75% of Medicare Advantage denials reversed on appeal. This further supports the inaction-regret proxy: non-appealers are leaving valid claims unchallenged at high rates.
Catatan
PENGUKURAN PROXY DI SELURUH BAGIAN. Tidak ada survei terpublikasi yang menanyakan individu "apakah Anda menyesali tidak membanding penolakan asuransi Anda?" Kedua sisi dibangun dari data klaim dan statistik hasil, bukan survei penyesalan. Perkiraan penyesalan-ketidakaktifan (44%) adalah proxy biaya-kesempatan: itu mewakili bagian dari non-pembanding yang kemungkinan kehilangan pertanggungan yang dapat mereka pulihkan, bukan bagian yang secara eksplisit menyesali pilihan mereka. Banyak non-pembanding mungkin tidak menyadari bahwa mereka dapat membanding, mungkin kekurangan waktu atau kesehatan untuk mengejar banding, atau mungkin telah menerima penolakan sebagai definitif. Ketidaktahuan tidak identik dengan penyesalan. Tingkat keberhasilan ACA 34% dan tingkat pembalikan Medicare Advantage 75% berlaku untuk populasi berbeda dengan jenis klaim berbeda; menggunakan keduanya bersama untuk mengelilingi perkiraan penyesalan-ketidakaktifan memerlukan kehati-hatian. Tingkat penolakan sangat bervariasi menurut penanggung dan jenis klaim: kesalahan penagihan rutin (mayoritas penolakan berdasarkan volume) lebih mudah dibalikkan daripada sengketa otorisasi awal untuk perawatan eksperimental. Proses banding untuk rencana ACA Marketplace melibatkan tahap-tahap berbeda: banding internal (30–60 hari standar; 72 jam dipercepat), peninjauan eksternal (45 hari standar; 72 jam dipercepat), dan untuk rencana ERISA, potensi litigasi federal. Beban berskala dengan tahap: banding internal adalah surat tertulis; sidang ALJ memerlukan persiapan dan kadang nasihat hukum. Kendala waktu dan kapasitas adalah hambatan nyata bagi pasien yang mengelola penyakit serius, yang merupakan populasi paling mungkin memiliki penolakan signifikan. Perkiraan penyesalan-tindakan (14%) terutama mencerminkan biaya waktu dan emosional dari proses ketika banding gagal, bukan biaya finansial — kehilangan banding mengembalikan pengklaim tepat ke tempat mereka sebelum membanding.
